Detection of Antiretrovirals in Transgender Women With HIV Is Not Altered by Hair Treatments
J Acquir Immune Defic Syndr
.
2023 Nov 1;94(3):e3-e5.
doi: 10.1097/QAI.0000000000003275.
Authors
Violeta J Rodriguez
1
2
,
Maria L Alcaide
3
,
Omar Sued
4
5
,
Ines Aristegui
4
,
Pablo D Radusky
4
6
,
Sofia Kozlova
1
,
Nadir Cardozo
4
,
Emanuel Dell'Isola
4
,
Monica Gandhi
7
,
Deborah L Jones
3
Affiliations
1
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL.
2
Department of Psychology, University of Illinois, Urbana-Champaign, Champaign, IL.
3
Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.
4
Fundación Huésped, Buenos Aires, Argentina.
5
Currently, Pan American Health Organization, Washington, DC.
6
Department of Psychology, Universidad de Buenos Aires, Buenos Aires, Argentina.
7
Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, CA.
PMID:
37850983
PMCID:
PMC10593490
DOI:
10.1097/QAI.0000000000003275
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Anti-Retroviral Agents / therapeutic use
Female
HIV Infections* / drug therapy
Hair
Humans
Transgender Persons*
Substances
Anti-Retroviral Agents
Grants and funding
R36 MH127838/MH/NIMH NIH HHS/United States
P30 MH116867/MH/NIMH NIH HHS/United States
R01 MH110242/MH/NIMH NIH HHS/United States
P30 MH133399/MH/NIMH NIH HHS/United States
P30 AI073961/AI/NIAID NIH HHS/United States
R37 AI098472/AI/NIAID NIH HHS/United States
R01 AI098472/AI/NIAID NIH HHS/United States
R01 DA059291/DA/NIDA NIH HHS/United States